Original Contributions |
From the Department of Electrical and Computer Engineering (A.N., J.W.C., D.S.L.), Rice University, Houston, Tex, and the Department of Physiology and Biophysics (C.F., L.F., R.B.C., W.R.G.), University of Calgary (Canada) Medical School.
Correspondence to Dr J.W. Clark, Department of Electrical and Computer Engineering, Rice University, 6100 South Main, Houston, TX 77005-1892. E-mail jwc{at}rice.edu
| Abstract |
|---|
|
|
|---|
Key Words: human atrium repolarization sustained outward current computer modeling cardiac action potential
| Introduction |
|---|
|
|
|---|
There are a number of published mathematical models that simulate the electrophysiological responses in several different species and cardiac cell types. Examples include the Purkinje fiber model of DiFrancesco and Noble,3 the Hilgemann and Noble atrial model,4 the Earm and Noble model of the single atrial cell,5 the bullfrog atrial and sinus venosus models of Rasmusson and colleagues,6 7 the ventricular cell models of Luo and Rudy,8 9 10 11 the rabbit sinoatrial node cell model of Demir et al,12 and the rabbit atrial cell model of Lindblad et al.13 Recently, the emphasis has shifted from general models, based on voltage-clamp data from several species,3 4 to more detailed models based on data from single isolated cells from a particular species. This is a direct reflection of the progress made in experimental work and the resulting availability of more comprehensive data. Our goal was to develop a model that is sufficiently accurate to have predictive capabilities for selected aspects of the electrophysiological responses in human atrium. Emphasis has been placed on the functional roles of the K+ currents during repolarization.
| Materials and Methods |
|---|
|
|
|---|
|
Membrane Currents
Fig 1A
shows the electrical equivalent circuit for the
sarcolemma of the human atrial cell. It includes each of the ionic
currents that are known to contribute to the action potential in human
atrial myocytes (INa,
ICa,L, It,
Isus, IK,r,
IK,s, and IK1), the
Ca2+ and Na+-K+ pump and
Na+-Ca2+ exchanger currents responsible for
maintaining intracellular ion concentrations (ICaP,
INaK, and INaCa), and the
Na+ and Ca2+ background (leakage) currents
(IB,Na and IB,Ca).
Mathematical expressions describing the time and voltage dependence of
the ionic currents have been developed on the basis of published
voltage-clamp data recorded predominantly from human atrial
myocytes. (See "Glossary" after Appendix 2
for terms used in text,
figures, and tables.)
Na+ Current: INa
Voltage-clamp data for INa in human
atrial and ventricular myocytes, recorded at 17°C
have been published by Sakakibara and colleagues.15 16
These data suggest that the activation threshold is very close to the
resting potential (
-75 mV), which seems unrealistic, given that
atrial and ventricular cells exhibit stable resting
potentials and thresholds for activation near -55 mV. Moreover, the
steady-state inactivation curves measured by Sakakibara and
colleagues15 16 are such that INa
would be completely inactivated (ie, no current available)
at the resting potential. As pointed out by these authors, this is
probably a result of time- and/or temperature-dependent shifts in the
steady-state inactivation characteristics. Other results, such as the
data from rabbit atrium published by Wendt et al17 (on
which the INa description in the LMCG model is
based) yield more positive (depolarized) steady-state activation and
inactivation curves.
In developing a model of INa under
physiological conditions, we have found it
necessary to use indirect information about INa
provided by action potential data in addition to voltage-clamp data.
Thus, we have adjusted the steady-state activation curve
(
3) for INa so
that the threshold at which an action potential is elicited agrees with
experimental observations. Furthermore, the peak magnitude of
INa was adjusted to match the maximum upstroke
velocity of the action potential. (For a discussion of the relation
between INa and action potential upstroke
velocity, refer to Cohen and Strichartz.18 ) Fig 2A
shows the steady-state activation
(
3) and inactivation (
)
curves used to model INa. Compared with the data
from human atrial myocytes obtained by Sakakibara et al15
(Fig 2A
), there are significant positive shifts in both the
3 (+22.8 mV) and the
(+32.2 mV) curves. Fig 2B
shows a simulated peak current-voltage
relationship (steps from a holding potential of -80 mV) for
INa. The mathematical expressions for the
kinetics of activation (
m) and inactivation
(
h1 and
h2) are very similar to those of
the LMCG model, as shown in Figs 2C
and 2D
. The processes of
inactivation and recovery from inactivation are both described by the
sum of a fast and a slow exponential. At plateau potentials, the fast
component of inactivation has a time constant of 0.3 ms. The slow
component of inactivation accounts for 10% of the total current and
has a time constant of 3.0 ms at plateau potentials; ie, it is 10 times
slower than the fast component, in agreement with the data of
Sakakibara et al.15
|
L-Type Ca2+ Current:
ICa,L
Several quite comprehensive studies of
ICa,L in human atrial myocytes have been
published.19 20 21 22 23 24 25 Overall, the results are quite
consistent: ICa,L has an activation
threshold near -40 mV, its peak at
0 mV, and an apparent reversal
potential of +50 to +60 mV. The current density for
ICa,L varies considerably among these studies,
however, and is also known to be reduced in diseased or dilated
cells.22 26 Table 1
shows
published ICa,L densities compared with those
used in the present model. The inactivation process for
ICa,L is usually described as the sum of a fast
and a slow component.19 20 21 22 23 In order to accurately measure
the steady-state voltage dependence of inactivation, the duration of
the "conditioning" prepulse in the voltage-clamp protocol (eg, see
Li and Nattel25 ) must be at least four to five times the
time constant of the slower component of inactivation. If the prepulse
duration is shorter, the slower component will not have reached its
steady state when the availability of current is measured (second
voltage-clamp pulse), and inactivation will appear incomplete. Ouadid
et al24 measured inactivation at room temperature (where
the slower time constant exceeds 100 ms23) and found that
inactivation was incomplete (U-shaped inactivation curve) when the
prepulse duration was 150 ms but that it became more complete if the
prepulse duration was increased to 400 ms. The data obtained by Li and
Nattel at 36°C yield almost complete inactivation characteristics for
a prepulse duration of 150 ms, consistent with faster kinetics
at this temperature. However, these authors also note that prolonging
the prepulse results in more complete inactivation curves. On the basis
of these results, we have modeled inactivation of
ICa,L as a process involving two components with
different time constants but identical, fully inactivating,
steady-state voltage dependence. This formulation differs from the LMCG
model13 as well as the Luo-Rudy model,9 which
both use a single (voltage-dependent) component of inactivation with
incomplete steady-state voltage dependence.
|
Ouadid et al24 also report that the inactivation process is slowed considerably when Ba2+ is substituted for Ca2+ as charge carrier, indicating that inactivation is also Ca2+ dependent. This phenomenon is included in the Luo-Rudy model9 but not in the LMCG model.13 Our formulation differs from that of Luo and Rudy, however, in order to incorporate recent experimental results. First, there is now evidence that there exists a small restricted subsarcolemmal domain between the L-type Ca2+ channels and the peripheral junctional sarcoplasmic reticulum (SR) where Ca2+ concentration ([Ca2+]d) may transiently reach much higher levels than in the cytosol as a whole.27 This subsarcolemmal domain is not included in the Luo-Rudy model, which models Ca2+-dependent inactivation as a function of total cytosolic Ca2+ concentration. We have included such a subsarcolemmal domain and have modeled Ca2+-dependent inactivation as a function of [Ca2+]d. Second, there is recent evidence to suggest that [Ca2+]d modulates ICa,L inactivation by promoting a rapid mode of inactivation.28 29 Therefore, in our model, [Ca2+]d determines the fraction of L-type channels that are in the rapidly inactivating mode, ie, the ratio of the fast to slow components of inactivation discussed above. Thus, in this model, an experiment with Ba2+ as charge carrier shifted this equilibrium so that all L-type channels were in the slow mode. With Ca2+ as charge carrier, however, the equilibrium is shifted toward the faster mode of inactivation by an amount determined by [Ca2+]d. Hence, the inactivation of the total ICa,L follows a biexponential time course, where the relative contributions of the fast and slow exponentials are determined by [Ca2+]d. We have chosen to model this [Ca2+]d dependence as an instantaneous function of [Ca2+]d, assuming that the shift between the two modes is rapid compared with the diffusion of Ca2+ out of the restricted domain.
Fig 3A
shows the steady-state activation
(dL) and inactivation
(fL) curves used to model
ICa,L. Assuming that activation can be measured
more accurately at room temperature than at
physiological temperature, we have used the
activation curve (dL) measured by Mewes and
Ravens.23 However, in order to fit the voltage-clamp data
(peak currents) of Li and Nattel25 (Fig 3B
), we found it
necessary to shift this activation curve by +3 mV. The expression for
the inactivation curve (fL) is identical to that
reported by Li and Nattel for human atrial myocytes at
physiological temperature. Furthermore, the
reversal potential for ICa,L is set to a
constant value of +60.0 mV, as measured by Li and Nattel, rather than
to the Nernst potential for Ca2+ ions. As shown in Fig 3B
, the simulated peak current-voltage relationship (steps from a holding
potential of -80 mV) agrees well with voltage-clamp data. Figs 3C
and 3D
show the time constants of activation (
dL) and
inactivation (
fL1 and
fL2) plotted
against membrane voltage. We have used the inactivation and recovery
time constant data obtained by Li and Nattel to formulate the
expressions for
fL1 and
fL2 (see Fig 3D
).
These data were obtained in human atrial myocytes at
physiological temperature. The expression for
dL (Fig 3C
) is similar to that of the LMCG model.
|
Transient and Sustained Outward K+
Currents: It and
Isus
Voltage-clamp experiments designed to study the outward currents
responsible for repolarization in human atrial myocytes have identified
a transient outward K+ current (denoted
It), which activates rapidly on
depolarization.1 30 In addition to this
(Ca2+-independent) transient K+ current, a
Ca2+-dependent transient outward current, which is
activated by relatively large increases in
[Ca2+]i, is sometimes observed.31
We have chosen not to include this Ca2+-dependent current,
since it has never been observed in our experimental work. After
It has decayed (inactivated), a more
slowly inactivating, "sustained," outward K+ current
(denoted Isus) is
observed.2 22 32 33 The available data suggest that
Isus is a separate current from
It and that it is also carried mainly by
K+ ions.2 34 35
The literature regarding the voltage dependence of
It is somewhat inconsistent. In
particular, the results regarding steady-state activation vary
considerably. Shibata et al1 report a half-activation
voltage (V1/2) of +1.0 mV for It in
human atrium, whereas Näbauer et al,36 Wettwer et
al33 (both in studies of human ventricle), and Le Grand et
al22 (human atrium) report values of +16.7, +20.6, and
+33.3 mV, respectively. These results seem unrealistic, since
It is known to have a strong influence on early
repolarization,1 2 and these values of V1/2
would result in only a small amount of It
current being activated during a normal action potential (peak
at +20 to +30 mV). Among the possible explanations for this variability
in V1/2 are the sensitivity of this parameter
to the concentration of divalent cations (Cd2+ and
Co2+) used to block
ICa,L33 37 and the possibility of a
difference between human atrial and ventricular
It. Therefore, we have based our model on the
data of Shibata et al,1 which were recorded from human
atrium in the presence of a low (100 µmol/L)
[Cd2+]. The data regarding the voltage dependence of
steady-state inactivation are also variable between different
studies. Fig 4A
shows the steady-state
activation (
) and inactivation (
)
curves used to model It. The
curve is based on a fit to data from Shibata et al (
in Fig 4A
), and
the
curve is that reported by Firek and
Giles.2 Time constants of activation (
r) and
inactivation (
s) are plotted against voltage in Fig 4C
and 4D
, respectively. Data regarding the time constant of
inactivation2 indicate that
s is
13 ms
(at 33°C) at membrane voltages positive to 0 mV. At hyperpolarized
potentials, the recovery of It from inactivation
as measured in our laboratory appears to follow an exponential time
course with a strongly voltage-dependent time constant, increasing from
15 ms at -100 mV to 387 ms at -60 mV. Our formulation for
s is based on a fit to experimentally obtained recovery
time constant values at negative potentials and inactivation time
constant values at positive potentials. The recovery of
It from inactivation in human atrial cells has
been shown to be considerably more rapid than in rabbit atrial
cells.2 38 As a result, It magnitude
and action potential waveshape are much less rate dependent in human
atrial cells.
|
Our model of Isus is based on the data of Wang
et al.35 Fig 4B
and 4D
show the steady-state activation
curve (rsus) and time constant of activation
(
rsus) for this current. On the basis of our recent
data, we have also included a slow (
300.0 ms) partial (40%)
inactivation. The time constant for this inactivation process was
obtained by fitting a biexponential function to the decaying outward
current waveforms as described by Koidl et al.39 In
addition to providing an estimate of
ssus, this method
also provides a more accurate separation of It
and Isus than when Isus
is estimated as the current at the end of the pulse.2 35 40
By combining our models of It and
Isus, we are able to produce current waveforms
closely resembling those recorded from human atrial myocytes in
response to voltage-clamp pulses. Fig 5
shows how It (panel A) and
Isus (panel B) combine (panel C) to produce
waveforms similar to experimental results (panel D). In our experience,
the size of these currents varies considerably between individual
cells, and as reported by Amos et al,40 there is also
considerable variability in the ratio of It to
Isus. The sizes of It and
Isus in the model were chosen to provide good
fits to action potential data and are well within this experimental
variability. Table 2
compares
It and Isus densities
reported in the literature with those used in this model.
|
|
Delayed Rectifier K+ Currents:
IK,r and IK,s
Recent studies of the delayed rectifier K+ currents
in human and rabbit atrial myocytes show that in both species the
delayed rectifier current is generated by two distinct K+
conductances. These "rapid" (IK,r) and
"slow" (IK,s) conductances have
significantly different properties and can be separated experimentally
on the basis of, for example, the sensitivity of
IK,r, but not IK,s, to
the antiarrhythmic drug E-4031.41 42 43 Since
IK,s is believed to contribute only a small
fraction of the total delayed rectifier current during a normal atrial
action potential,41 one could produce an acceptable fit to
nominal action potential data using a model incorporating only
IK,r. However, because of the very slow
activation characteristics of IK,s, this current
would be expected to be more significant at high heart rates, where it
could build up progressively from cycle to cycle as a result of
residual activation, ie, failure to decay completely between cycles.
Therefore, we have chosen to include both IK,r
and IK,s in our model, thus enabling it to
simulate specific effects of antiarrhythmic drugs on
IK,r, the buildup of IK,s
at elevated heart rates, and the resulting changes, such as those in
action potential duration (APD) and refractory period.
Our model of IK,r is based on data from Wang et
al,44 Muraki et al,41 and Sanguinetti et
al.45 Figs 6A
and 6C
show the
steady-state activation (
a) and
inactivation (
i) curves and the time
constant of activation (
pa) compared with the available
data. Since the inactivation of IK,r is very
rapid compared with the activation, inactivation is modeled as being
instantaneous. The expressions for IK,s are
based on data recorded in human atrial myocytes by Wang and
colleagues.42 44 Figs 6B
and 6D
show the characteristics of
this current.
|
In order to verify our model of IK,r we chose to
simulate the "ramp clamp" experiment of Muraki et al41
in rabbit atrial cells (their Fig 7
), in which the cell is subjected to
an 0.8-V/s repolarizing ramp from an action potential peak potential
down to -80 mV. This waveform is an approximation to the
repolarization phase of an atrial action potential. The result
(simulated response) is shown in Fig 7
, along with data from Muraki et al. Note that the simulated waveform is
very similar, although in order to fit action potential data, we have
had to reduce the size of IK,r to 15% of that
shown in Fig 7
. Given that it is often difficult to detect any delayed
rectifier current at all in most human atrial myocytes,2 it
seems reasonable that this current should be assigned a very low
density.
|
Time-Independent Currents: IK1,
IB,Na, IB,Ca,
INaK, INaCa, and
ICaP
In the absence of reliable published data from human atrial
cells for these currents, we have used expressions from the LMCG
model13 with only minor scaling adjustments. One exception
is the inward rectifier current, where we have found it necessary to
make minor modifications to the rectifying characteristics in order to
fit action potential data (slightly narrower outward "hump"). We
have also adjusted the [K+]c dependence of
IK1 to agree with data from our laboratory.
Table 3
lists the changes made in the
time-independent currents compared with those in the LMCG
model.
|
Material Balance
As in the LMCG model,13 we have included a fluid
compartment formulation to monitor and account for changes in ion
concentrations. These concentration changes can be a result of current
flow across the cell membrane or of redistribution of ions within the
cell (eg, uptake of Ca2+ by the SR or binding of
Ca2+ to an intracellular buffer). Our fluid compartment
model is similar to the one in the LMCG model. It includes descriptions
of extracellular and intracellular spaces, formulations for
Ca2+ uptake and release and the buffering action of
calsequestrin, and troponin and calmodulin buffers in the
intracellular medium. Compartment volumes and other ultrastructural
properties, as well as expressions describing the binding of
Ca2+ to intracellular troponin and calmodulin
buffers and to calsequestrin in the SR release compartment, are
identical to those of the LMCG model, except as noted in the following
sections.
Cleft Space
We have included a "cleft space" in our fluid compartment
formulation, ie, a small restricted space surrounding the cell, in
which accumulation or depletion of ions may occur (see Demir et
al12 ). The cleft space is modeled as an unstirred fluid
layer; ie, ions can be exchanged between the cleft space and the
extracellular medium (in which all concentrations are assumed constant)
only through diffusion as a result of a concentration gradient. Ratios
between diffusion time constants for the ions involved
(
Na,
K, and
Ca) were
calculated from values for ionic conductivity46 and the
composition of the extracellular solution
([Cl-]o=140 mmol/L,
[Na+]o=130 mmol/L,
[K+]o=5.4 mmol/L, and
[Ca2+]o=1.8 mmol/L). We have adjusted
the size and diffusion properties of the cleft space so as to produce
oscillations in cleft space [K+]
([K+]c) similar to experimental
data.47 48
Electroneutral Na+ Influx
In order to achieve long-term stability in the ionic
concentrations in the model, we have found it necessary to add a small
(1.68-pA) electroneutral inward flux of Na+, denoted
Na,en. This flux could, for example, be accounted for in
terms of electroneutral coupled transport mechanisms, such as
Na+-H+ exchange and
Na+-K+-2Cl cotransport. Modeling of these
mechanisms, however, is beyond the scope of this work.
There are two major reasons for including this flux: First, the fact that long-term ionic homeostasis can be achieved with the addition of this small flux demonstrates that the sizes and other characteristics of the model elements are such that ionic homeostasis can reasonably be maintained. Second, if the ionic concentrations were allowed to change slowly from cycle to cycle (which would be the result if this flux were not included), the model would only be valid for short simulation times (seconds), for which this drift can safely be ignored. By ensuring long-term stability of the ionic concentrations, longer simulation times (minutes) become feasible and meaningful. Only with stable ionic concentrations can the model be used to simulate concentration changes as a result of rate changes or other interventions.
Sarcoplasmic Reticulum
Our formulation for the SR is very similar to that of the LMCG
model. However, we have made one important modification in accordance
with recent evidence demonstrating that Ca2+ can accumulate
in a small domain between the sarcolemma and the peripheral
junctional SR and trigger Ca2+ release.27 49
Specifically, we have removed the voltage-dependent term in the
formulation for activation of SR Ca2+ release and replaced
it with a term dependent on Ca2+ concentration in the
restricted subsarcolemmal domain, [Ca2+]d.
The sole mechanism for SR Ca2+ release in our model is
therefore Ca2+-induced Ca2+ release (CICR). Fig 1B
includes a schematic representation of the model of the
SR.
Stern50 has shown that in order for a CICR model to be
stable, ie, capable of producing a response that is graded by the
amount of Ca2+ that enters the cell through
ICa,L, the trigger Ca2+ has to be
separated from that released from the SR. Anatomically, this can be
understood in terms of the concept of "release units" discussed,
for example, by Isenberg and Han.51 According to this
concept, Ca2+ release from the SR is recruited stepwise by
the all-or-none activation of individual release units, consisting of
one or more L-type Ca2+ channel and associated SR release
channels. The activation of a release unit results in CICR within that
unit only. The released Ca2+ then diffuses into the
myoplasm, without directly affecting other units. This phenomenon has
been incorporated in our model as a lumped mechanism, where the SR
release channel senses [Ca2+] in the restricted domain
([Ca2+]d) but releases Ca2+
directly to the cytosol (Fig 1B
), thus separating trigger
Ca2+ from that released from the SR.
Parameter Values
A model of this type contains a large number of
parameters that must be assigned values based on the
available data. We have approached this part of the model development
process in a two-step fashion, where the majority of the
parameter values have been assigned in the first step,
based on experimental studies of individual model components. This has
the advantage that most of the parameters associated with
an individual membrane current can be justified and assigned
independently. Once the descriptions of individual membrane currents
has been completed, one is left with a limited number of free
parameters, most of which are scaling factors, such as the
maximum conductance values for each ionic current. These remaining free
parameters can then be determined using data for whole-cell
responses (eg, action potential waveforms) or other constraints as
indicated previously (eg, ionic homeostasis). It should be emphasized,
however, that model development is very much an iterative process and
that it has been necessary in some cases to modify individual current
expressions to obtain acceptable fits to action potential data or (as
in the case of INa) to use information from
action potential recordings to resolve ambiguities in ion
channel current data. The following sections describe the constraints
and criteria used in order to assign values for the remaining free
parameters.
The Quiescent Human Atrial Myocyte
In the absence of an external stimulus, a healthy human atrial
cell is quiescent (does not contract or produce an action potential).
In this quiescent state, the membrane potential comes to an
equilibrium, "resting," potential at which the net ion flux across
the sarcolemma is zero. The resting membrane potential varies somewhat
among individual cells, ranging from -70 to -80 mV. The resting
membrane potential is the result of a precise balance between the
time-independent background, pump, and exchanger currents
(IK1, IB,Na,
IB,Ca, INaK,
ICaP, and INaCa).
Although the resting state of the cell may seem less interesting than
the active state during an action potential, an accurate description of
the resting conditions is, in our experience, essential for successful
modeling of the action potential. Moreover, the model of the resting
state of the cell determines very important threshold characteristics
and subthreshold properties, such as the input resistance of the cell.
Very accurate simulation of these passive characteristics is essential
before the cell model is to be used in distributed simulations, eg, of
the propagation of electrical activity from one cell to another. We
have modeled the resting state of the cell by adjusting the magnitudes
of these currents so as to produce zero net transmembrane current at a
resting potential of
75 mV and the following intracellular ion
concentrations: [Na+]i
8.5 mmol/L;
[K+]i
130.0 mmol/L, and
[Ca2+]i
60.0 nmol/L. The input resistance
of the cell in this quiescent state is
600 M
, which agrees with
our experimentally observed values.
The Activated Human Atrial Myocyte
When the cell is stimulated, it produces an action potential,
the shape of which depends on the relative sizes of the ionic currents
involved. Action potential data recorded from isolated human atrial
myocytes are (in our experience) quite variable from cell to cell.
It is therefore questionable whether it is possible to define the
"normal human atrial action potential" in a meaningful way. We have
chosen to fit our model to an action potential waveform that is
representative of what is most often recorded
from isolated human atrial cells in our laboratory. By establishing
this "nominal model," we have obtained a starting point from which
the sensitivity of the action potential waveform to
parameter perturbations may be studied (see "Results").
In addition to dictating the action potential waveform, the sizes
(maximum conductance parameters) of the ionic currents also
affect ionic homeostasis. The membrane currents involved in shaping the
action potential therefore have to act in concert with those involved
in the resting state to maintain constant ion concentrations at nominal
stimulation rates. We have "tuned" our model so that ion
concentrations remain constant from cycle to cycle at a stimulus
frequency of 1 Hz.
| Results |
|---|
|
|
|---|
Simulated Action Potential Waveform
Fig 8A
shows a simulated action
potential waveform (solid line) compared with an action potential
(dotted line) recorded at a temperature of 33°C and a stimulus
frequency of 0.5 Hz. There is close agreement between the waveforms
(the discrepancy at the beginning of the upstroke is due to a
stimulation artifact that is not simulated). As mentioned previously,
the action potential waveform varies significantly among individual
cells and in multicellular preparations from the human atrium,
presumably because of variations in the magnitudes of the underlying
ionic currents. Nevertheless, the ability of this model to accurately
reproduce a recorded action potential, in combination with the
previously demonstrated fits to voltage-clamp data, lends credibility
to the model.
|
In Fig 8
, panels B and C show the behavior of the membrane currents
during an action potential. The first current to respond to a
depolarizing stimulus pulse (delivered at time=100 ms) is
INa, which activates rapidly, resulting
in a very large but transient inward current. Note that
INa is too large to be shown on the scale of Fig 8B
; its peak magnitude is
-5.8 nA, which corresponds to a maximum
upstroke velocity of 116 V/s. INa is primarily
responsible for the upstroke (phase 0) of the action potential, but as
seen from Fig 8B
, a substantial amount of INa
remains during the early peak phase of the action potential as a result
of the second slower component of INa
inactivation.
On depolarization of the cell, It, Isus, and ICa,L are also activated. However, It and Isus reach their peak magnitude faster than ICa,L, and their combined magnitude is thus larger than that of ICa,L early in the action potential. (This is because the peak of the action potential is close to the reversal potential for ICa,L.) The initial result on the action potential waveform is therefore a period of relatively rapid repolarization (phase 1), dominated by It. Since the time course of inactivation of ICa,L is slow compared with that of It, the net current gradually becomes dominated by ICa,L and Isus. A situation where the repolarizing effect of Isus (and the remaining It) is balanced by the depolarizing effect of ICa,L results. In the action potential waveform, the initial rapid repolarization (phase 1) is followed by a period during which the membrane potential levels off, forming a plateau (phase 2). Finally, as ICa,L slowly inactivates, the repolarizing effects of Isus become dominant, and the action potential enters its final repolarization phase (phase 3). During this phase, Isus is aided by the inward rectifier current, IK1, and the delayed rectifier currents, IK,r and IK,s, in repolarizing the cell membrane back to the resting potential (phase 4).
Simulated Ionic Fluxes
The fluid compartment part of this model monitors ion
concentrations in the intracellular and cleft spaces. Valid modeling of
the action potential requires not only the reconstruction of the action
potential waveform but also a demonstration that this can be
accomplished under conditions of ionic homeostasis at nominal heart
rates. Table 4
shows how our model has
been tuned to achieve homeostasis at 1 Hz. The average charge
transported across the sarcolemma for each ionic current has been
computed by integrating each current over one cycle (1 s in the case of
a quiescent, nonstimulated cell). Note that the sums of these average
charges are zero for all ionic species at a stimulus rate of 1 Hz
(Table 4
). When the cell is quiescent, there is a small net loss of
intracellular Na+ and gain of intracellular K+.
The existence of such an ionic imbalance at quiescence is supported by
the observation by Bénardeau et al52 that trains of
depolarizing pulses that activate INa
can be used to hyperpolarize the resting potential of human atrial
cells after a period of quiescence. As suggested by these authors, the
hyperpolarization and stabilization of the resting
potential may be caused by activation of the
Na+-K+ pump after Na+ entry during
the train of pulses. In our model, at a 2-Hz stimulus rate there will
be a net gain of intracellular Na+ and loss of
K+.
|
Fig 9
illustrates the Ca2+
handling in the fluid compartment part of the model during the
simulated action potential. A transient increase in
[Ca2+]i occurs early in the action potential,
raising [Ca2+]i from the very low
diastolic levels (
65 nmol/L) to a peak of
1.3
µmol/L (Fig 9B
). This rise in [Ca2+]i is
primarily due to the rapid release of large amounts of Ca2+
from the SR (see Fig 9D
). Several processes are responsible for the
decline of the intracellular Ca2+ transient. The most
potent of these is the rapid binding of Ca2+ to the
intracellular Ca2+ buffers (troponin and
calmodulin), which is particularly important in shaping the
early portions of the Ca2+ transient. As seen in Fig 9C
, the occupancies on these buffers increase rapidly as Ca2+
is released from the SR, thus "removing" large amounts of free
Ca2+ from the cytosol. The uptake of Ca2+ by
the SR also has a pronounced effect on the shape of the
Ca2+ transient. This is also the primary pathway for actual
removal of Ca2+ from the cytosol (as opposed to the
"temporary storage" provided by the buffers), taking up
intracellular Ca2+ as it dissociates from the buffers. In
addition, some Ca2+ is removed from the cytosol via the
Na+-Ca2+ exchanger,
INaCa, and the Ca2+ pump,
ICaP. As seen in Table 4
,
INaCa and ICaP, on
average, remove the amounts of Ca2+ that were brought into
the cell via ICa,L and
IB,Ca and thereby prevent a progressive buildup
of cytosolic Ca2+ during repetitive stimulation.
|
Increasing the stimulus rate from the baseline (1 Hz) results in a
change in ion concentrations in the intracellular medium (Table 4
) as
well as in the cleft space surrounding the cell. For the ionic species
that exist in relatively low concentrations in the extracellular medium
(Ca2+ and K+), these changes can be
significant. Fig 10
shows how the
intracellular and cleft space concentrations change when the stimulus
rate is increased abruptly from 1 to 2 Hz. Note the progressive shift
in [K+]c of
1
mmol/L.47 48 In contrast, the change in
[Na+]c is negligible because of its high
baseline value of 130 mmol/L. If the simulation in Fig 10
is
continued beyond the 20 s shown, [K+]c
will reach a peak value of
6.3 mmol/L, after which it will
begin to decline as a result of increased INaK
activity due to increased [Na+]i and
[K+]c (simulation not shown). The asymptotic
values for [K+]c and
[Na+]i are 5.6 and 10.0 mmol/L,
respectively (reached after
10 minutes). This behavior is
consistent with experimental observations.47
|
Parameter Sensitivity of the Action Potential
Shape
As mentioned in the previous section, there is considerable
variation in action potential shape among individual cells from the
human atrium. Our working hypothesis is that many of these differences
in action potential waveshape can be explained in terms of differences
in the magnitudes of the ionic currents (caused by previous drug
treatment and/or natural variability). In order to investigate possible
mechanisms of action potential shape variability, it is therefore
necessary to have an understanding of how changes in the magnitudes of
different ionic currents affect the action potential shape. Such an
understanding is equally important, of course, in identifying suitable
"targets" for drug action aimed at modifying the action potential
shape.
A valid mathematical model provides a method for this sensitivity
analysis53 ; ie, it provides a method for studying
how sensitive the state variables (eg, membrane voltage) are to
perturbations in model parameters. We will restrict this
analysis to a study of the sensitivity of the action potential
waveform to changes in the sizes (maximum conductances) of the currents
involved in shaping the action potential, although this type of
analysis in principle can be used to study the sensitivity of
any state variable to perturbations in any model
parameter. Briefly, sensitivity analysis involves
the computation of the partial derivative of the state variable of
interest (in this case, membrane voltage) with respect to a model
parameter. We have chosen to normalize these partial
derivatives with respect to the nominal value of each
parameter. Thus, we will present the results in terms
of sensitivity functions, defined as:
![]() |
Fig 11
shows the result of the
sensitivity analysis, ie, the sensitivity functions for the
membrane voltage (action potential) with respect to the
parameters of interest. Sensitivity functions were computed
for all maximum conductance parameters in the model as well
as for the scaling parameters for
INaK and INaCa. The
sensitivity functions for INa and
IK,s have been omitted from Fig 11
, since these
currents were found to have negligible influence on the action
potential shape (small sensitivity functions), except for the obvious
importance of INa during the upstroke. Several
of the sensitivity functions have maximum absolute values of
50 mV
during the late repolarization phase of the action potential. In other
words, a 10% change in either one of these parameters
would alter the membrane voltage by
5 mV during this phase of the
action potential. Although this estimate is based on a linearization
around the nominal parameter value and thus is most
accurate for small perturbations, it can provide an indication of the
approximate change expected for larger perturbations. Overall, we can
anticipate that changes in these parameters in the ±50%
range will produce significant changes in the action potential
waveform.
|
Perhaps more important than the absolute sensitivity values, however,
is the information provided by the time course of the sensitivity
functions. As the ionic conductances change during the action
potential, the sensitivity functions indicate which currents have the
greatest influence on the action potential shape at each point in time.
For example, it is clear that the action potential waveform is
sensitive to
t primarily early in the
peak phase of the action potential but that
sus and
Ca,L rapidly become more important early
in the plateau phase. Throughout the plateau phase,
|
sus| (absolute value) and |
Ca,L| are
larger than |
t|, and this portion of the action
potential waveform is therefore particularly sensitive to perturbations
in
sus and
Ca,L. Toward the end of repolarization,
the action potential becomes very sensitive to the size of the
time-independent currents involved in maintaining the resting
potential. This analysis shows that (under the hypothesis that
action potential changes can be explained in terms of changes in the
magnitudes of ionic currents)
t,
sus, and
Ca,L are the most important model
parameters in determining the action potential waveshape
during the peak and plateau phases of the action potential.
Roles of It and
Isus in Repolarization
The effects on the human atrial action potential of blocking
It with agents such as
4-aminopyridine, flecainide, and quinidine have been
described in the literature.2 54 55 56 Partial block of
It results in a slowing of the rate of
repolarization of the action potential, particularly during the early
repolarization phase (phase 1). This is, of course, consistent
with the characteristics of It, and its role in
the generation of the action potential as indicated by sensitivity
analysis. In a recent study of the effects of some
antiarrhythmic agents on It and
Isus, Wang et al56 found that
quinidine, in addition to blocking It, has a
pronounced effect on Isus at clinically relevant
concentrations. Considering that our sensitivity analysis
indicates a prominent role for Isus in
repolarization, the APD is expected to be quite sensitive to modulation
of Isus magnitude. A detailed account of the
role of It and Isus in
the repolarization of the human atrial action potential is therefore
essential for understanding the antiarrhythmic actions of
quinidine.
Since pharmacological blocking agents used in experimental work usually affect more than one current and since their effects are often rate dependent, it is difficult to gain a quantitative understanding of the importance of a particular current (It or Isus) in repolarization from experimental results alone. In a computer model, however, it is possible to alter the characteristics of one ionic current in a controlled fashion, while leaving all other currents unaffected. Such simulations can be a valuable complement to experimental work. Given that drugs that prolong the APD (class III drugs) have been shown to be effective in the treatment of atrial arrhythmias,57 a thorough understanding of the influence of different ionic currents on the APD is needed.
Fig 12A
shows the effects on the action
potential of various degrees (30%, 60%, and 90%) of block of
It. (In the present study, an x% block of
It is simulated as an x% reduction in the
maximum conductance,
t.) As observed
experimentally, It block results in a broadening
of the action potential peak during phase 1 of repolarization (refer to
Fig 2 in Firek and Giles2 ). In addition, because of the
elevation of the action potential peak and plateau levels, the
contribution of Isus to repolarization is
increased. The resulting prolongation of the APD is therefore only
moderate, even for substantial reductions of It
size. Fig 12B
shows the effects of various degrees (15%, 30%, and
45%) of block of Isus on the action potential.
In contrast to It block, inhibition of
Isus primarily affects the plateau phase of the
action potential, with little or no effect on the action potential
peak. As a result, Isus block produces a more
pronounced prolongation of the APD than does It
block. For example, 30% block of Isus results
in a 15% increase in APD at 90% repolarization (APD90)
compared with the 5% increase in APD90 resulting from 30%
It block. Many antiarrhythmic agents have
effects on several ion channels. For example, according to Wang et
al,56 quinidine blocks both It and
Isus (in addition to its effects on
Na+ channels). It is therefore of interest to study the
effects on the action potential of combined It
and Isus block. Fig 12C
shows the result of a
simulation in which both It and
Isus have been reduced by 40% (approximately
corresponding to the effect of 5 µmol/L quinidine at a stimulus
rate of 1 Hz56). As expected, the result is essentially a
combination of the previously demonstrated effects of
It and Isus block, ie, a
widened peak, an elevated action potential plateau, and a prolongation
of APD90 of 27%.
|
Modulation of the Role of Isus by
Baseline ICa,L,
Isus, and
IK,r Sizes
As discussed in "Model Development," published data regarding
the size of ICa,L and
Isus are quite variable. Both these currents
(as well as It) are known to be depressed in
diseased human atrial cells22 26 and modulated by
adrenergic stimulation.26 58 Furthermore, a recent
study59 shows that the size of Isus
is significantly reduced in cells obtained from patients in chronic
atrial fibrillation compared with patients in normal sinus rhythm. It
is therefore likely that a range of sizes of these two currents
contributes to the physiological (and
pathophysiological) behavior of the human atrial
cell. Similarly, IK,r in our nominal model is
very small, which is consistent with observations from our
laboratory. Since results in other species60 indicate that
this may be a consequence of the cell isolation techniques used for
human atrial myocytes,2 this current may be considerably
larger in vivo. Given these uncertainties in the actual sizes of
several of the ionic currents, it is appropriate to investigate how the
conclusions reached above are affected by our assumptions for these
current sizes. We have chosen to focus on the role of
Isus in repolarization, since this current is an
important determinant of APD. Starting from our nominal model, we have
performed a large number of simulations for different combinations of
increased/decreased ICa,L,
Isus, and IK,r. All
simulations were performed at a stimulation rate of 1 Hz, and 20 cycles
were allowed after each change of parameter values in order
for any initial transient behavior to die out before the APD
prolongation was evaluated. Fig 13
shows how the APD prolongation resulting from a 50% reduction of
Isus depends on the baseline sizes of
ICa,L and IK,r.
ICa,L and IK,r sizes are
expressed as percentages of those in the nominal model; ie, the nominal
model corresponds to 100% of both currents. A 7-fold (700%) increase
in IK,r corresponds approximately to the size of
IK,r observed in rabbit atrial
myocytes.41 It is clear from Fig 13
that the role of
Isus as a major determinant of APD depends
strongly on the size of IK,r current. The action
potentials shown in the insets in Fig 13
provide an indication of the
underlying mechanism. When Isus is partially
blocked, the action potential plateau is depolarized, which in turn
increases the amount of IK,r (and
IK,s) that is activated. This effect,
which counteracts the APD-prolonging effect of
Isus block, becomes stronger as the size of
IK,r is increased. Similarly, Fig 14
shows how the APD prolongation as a
result of 50% Isus block depends on the
baseline sizes of ICa,L and
Isus. Again, the APD-prolonging effect of
Isus block is strongly dependent on the baseline
current densities. Generally, the APD prolongation as a result of
partial Isus block becomes larger as the
baseline size of ICa,L increases, provided that
the increase in ICa,L is balanced by a
comparable increase in Isus. Notice, however, in
Fig 13
as well as in Fig 14
, that when baseline
ICa,L is increased without such a comparable
increase in baseline outward current (Isus or
IK,r), the APD-prolonging effect of
Isus block is instead reduced. The underlying
mechanism in this case is that the action potential plateau, both
before and after Isus block, is prolonged and
depolarized somewhat by the larger ICa,L. As a
result, more IK,r (and
IK,s) is activated, and the final
repolarization phase becomes steeper and therefore less dependent on
Isus.
|
|
| Discussion |
|---|
|
|
|---|
We have developed a mathematical model of the human atrial cell based primarily on data recorded from enzymatically isolated single human atrial cells. Our model is capable of accurately reconstructing a recorded human atrial action potential and illustrates the functional roles of the ionic currents. In addition, our model maintains ionic homeostasis at a nominal stimulus rate, demonstrating that the reconstruction of the action potential is accomplished using plausible current densities. We used the LMCG rabbit atrial model13 as a "starting point" for the model development. As a result, these two formulations are very similar in some aspects, particularly for the membrane currents where incomplete (or no) data from human atrial cells are available. However, there are some important differences between the electrophysiological responses of rabbit and human atrial cells; these provided the motivation for the development of this human atrial cell model. Perhaps most striking is the small rate dependence of It in human atrial cells compared with the very prominent rate dependence seen in rabbit atrial cells.13 38 This is mainly due to differences in the rates of recovery from inactivation of It in the two species. As discussed in "Membrane Currents," It in human atrial cells recovers from inactivation much more rapidly than does It in rabbit atrial cells. Another important difference between human and rabbit atrial cells is the sustained outward current (denoted Isus in this article). Whereas this current in the rabbit atrium is believed to be carried mainly by Cl- ions,13 there is convincing evidence that Isus in human atrial cells is carried mainly by K+ ions.2 35 Both these differences are very important in studying the mechanisms of repolarization of the human atrial action potential and the effects of action potentialprolonging (class III) drugs that affect these currents.
Roles of It and
Isus in Repolarization
Both It and Isus
have important roles in the repolarization of the action potential of
human atrium. In particular, Isus, because of
its noninactivating characteristics, is necessary
for repolarization to the resting potential. This important role in
repolarization makes It and
Isus potential targets for class III
antiarrhythmic drugs, which are designed to prolong the APD. Indeed, a
recent study of flecainide and quinidine,56 both known to
prolong the human atrial action potential,54 55 shows that
both these drugs produce a partial block of It.
Quinidine also blocks Isus, which could explain
its greater efficacy (compared with flecainide) in prolonging the
APD.55 Our simulations of partial It
and Isus block (see "Results") produce
prolongations of the APD that are comparable to experimentally observed
effects of flecainide and quinidine, ie, a 27% prolongation of
APD90 when It and
Isus are both reduced by 40%. For comparison,
Wang et al55 reported that 2.25 µmol/L quinidine
increased APD95 by 33% in human atrial cells at a
stimulation rate of 1 Hz. It should be noted that only some of the
known effects of quinidine have been modeled; therefore, our results
cannot be directly compared with these experimental observations. For
example, the effects of quinidine on INa, as
well as the state dependence of It block by
quinidine,61 would have to be included in a more
comprehensive treatment of quinidine effects. Nevertheless, the
experimental observations agree very well with our model predictions
and provide an independent "test" of how well our model describes
the roles of It and Isus
in repolarization.
Action potential generation involves a complex interaction among the ionic currents in a given cell type. The role of a particular ionic current in the action potential is therefore not determined solely by the characteristics of that current. We have investigated how the role of Isus in repolarization is affected when the baseline densities of ICa,L, Isus, and IK,r are varied within ranges that are relevant to the physiological and pathophysiological behavior of the human atrial cell. Our results demonstrate that Isus block will, in general, result in a prolongation of the action potential. The amount of prolongation, however, depends quite strongly on the baseline current densities. If the human atrial cell is assumed to have an IK,r density comparable to that observed in the rabbit atrium41 or if the ICa,L and Isus densities are reduced as observed in diseased cells,22 26 the APD prolongation resulting from Isus block may be considerably smaller than indicated by our nominal model. The efficacy of a drug targeting Isus would therefore be expected to depend critically on the disease state of the tissue. For example, based on the recent observation by Van Wagoner et al59 that Isus density is reduced in cells obtained from patients in chronic atrial fibrillation, the efficacy of an Isus-blocking drug may be limited in these patients.
Limitations of the Model
When using our model to gain insight into the
electrophysiological responses of the human
atrial cell, it is important to be aware of certain limitations, which
are summarized by the following items:
1. The Hodgkin-Huxley formalism along with its concept of independent
activation and inactivation "gating" variables has some
important limitations. Notably, the processes of inactivation and
recovery from inactivation (and analogously activation and
deactivation) are governed by a single time constant. Experimental
observations, however, often indicate that inactivation and recovery
from inactivation occur with different time constants, even at the same
membrane potential. In order to overcome this problem, one would have
to use a more complicated modeling formalism that treats inactivation
and recovery as two separate processes. To reduce the computational
requirements of the model, we have chosen a "compromise" solution,
in which time constant values are determined by measured inactivation
kinetics at depolarized membrane potentials and by measured recovery
kinetics at hyperpolarized potentials. In cases in which the time
constants of inactivation and recovery are very different, this
compromise results in unconventional time constant expressions, such as
those for INa in Fig 2D
.
2. The available data regarding the intracellular Ca2+ transient and the Ca2+ handling in the SR have, with few exceptions,52 62 been recorded in cells from species other than humans. In addition, the understanding of the exact mechanisms involved in these phenomena is incomplete, and a quantitative model of SR Ca2+ release and uptake has not yet been developed. Our Ca2+-dependent formulation for SR Ca2+ release replaces the voltage-dependent formulation used in earlier models4 12 13 but is nevertheless only a qualitative description of this phenomenon. Other features of the SR function are the same as those in the LMCG model.13 Our SR formulation is therefore not based on human data.
3. The shape of the action potentials recorded from enzymatically isolated human atrial cells is variable, even at a fixed stimulus frequency. There are several reasons for this variability, including genuine heterogeneity between cells from different parts of the atrium, the disease states of the patients from whom the specimens are obtained, and the use of various drugs (eg, Ca2+ channel blockers and ß-blockers) by the donors. It is important to acknowledge that this variability exists and that the exact action potential waveform in the model is chosen because it is representative of the action potential shapes that are most often observed in our single cell records. As indicated by sensitivity analysis, the shape of the human atrial action potential as described by our model is quite sensitive to variations in the strengths of three ionic currents (It, Isus, and ICa,L). Under the assumption that the currents involved and their kinetic properties are unchanged, our results therefore suggest that the experimentally observed variation in action potential shape is caused mainly by variations in these currents and can be explained within the framework of our model. However, it is also conceivable that regional diversity in the molecular basis of the currents in human atrium could give rise to regional differences in kinetics and pharmacological sensitivity. Most of the data on human atrial electrophysiology to date have been obtained from samples of the atrial appendage, and there are therefore little experimental data available regarding regional differences in human atrium. If and when data to suggest regional diversity become available, our model should provide a useful framework for predicting the consequences.
4. Our model of Ca2+-dependent inactivation of ICa,L uses a single lumped subsarcolemmal compartment in which Ca2+ accumulates and is therefore limited in its ability to simulate the effect of Ca2+ accumulation in restricted spaces close to each L-type Ca2+ channel. In contrast to voltage-dependent gating, where it is reasonable to assume that the controlling variable (membrane voltage) is spatially uniform (space-clamp conditions), this is in all likelihood not the case for subsarcolemmal Ca2+. Since inactivation is a nonlinear function of [Ca2+]d, it is not strictly correct to use a formulation in which all channels are subject to one (average) Ca2+ concentration.
Notwithstanding these limitations, this model provides the most complete description available of the ionic mechanisms underlying the human atrial action potential, and it is based on the available data. As a result, it provides a very useful tool for investigating fundamental electrophysiological responses of the human atrial cell, such as excitability, refractoriness, and the action of channel blocking drugs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Appendix 1 |
|---|
|
|
|---|
All simulations were performed by forward integration of the coupled
system of differential equations using the CVODE solver package for
ordinary differential equations. (CVODE was developed by S.D. Cohen and
A.C. Hindmarsh at Lawrence Livermore National Laboratories, Livermore
Calif) Sufficient accuracy was ensured by adjusting the temporal step
size of the integration so that the local error in all state
variables (as estimated by the CVODE algorithm) satisfied a
relative error bound. Computer programs for the simulations were
written in the C programming language under the UNIX operating system.
Simulations were performed on Sun Microsystems Sparc workstations
(Sparc 2, IPX) and on a Micron Millennia Pentium 166 PC running the
Linux operating system. At a stimulus frequency of 1 Hz, one cycle (ie,
1 s of data) requires
0.9 s of CPU time on the Pentium 166
platform.
| Appendix 2 |
|---|
|
|
|---|
Starting from a system of the general form,
![]() |
k to obtain the following
equation:
![]() |
,
t) can be written as follows:
![]() |
vanishes, since all
parameters are assumed to be time invariant. Thus, from
Equation 1, we have the following:
![]() |
![]() |
k is the sensitivity of the state
x to the parameter
k, ie,
![]() |
![]() |
![]() |
Glossary
Na,
K,
Ca INa
Na+ current
ICa,L
L-type Ca2+ current
It
Transient outward K+ current
Isus
Sustained outward K+ current
IK,s
Slow delayed rectifier K+ current
IK,r
Rapid delayed rectifier K+ current
IK1
Inwardly rectifying K+ current
IB,Na
Background Na+ current
IB,Ca
Background Ca2+ current
INaK
Na+-K+ pump current
ICaP
Sarcolemmal Ca2+ pump current
INaCa
Na+-Ca2+ exchange current
Na,en
Electroneutral Na+ influx
Idi
Ca2+ diffusion current from the diffusion-restricted subsarcolemmal space to the cytosol
Iup
Sarcoplasmic reticulum Ca2+ uptake current
Itr
Sarcoplasmic reticulum Ca2+ translocation current (from uptake to release compartment)
Irel
Sarcoplasmic reticulum Ca2+ release current
[Na+]b
Na+ concentration in bulk (bathing) medium
[K+]b
K+ concentration in bulk (bathing) medium
[Ca2+]b
Ca2+ concentration in bulk (bathing) medium
[Na+]c
Na+ concentration in the extracellular cleft space
[K+]c
K+ concentration in the extracellular cleft space
[Ca2+]c
Ca2+ concentration in the extracellular cleft space
[Na+]i
Na+ concentration in the intracellular medium
[K+]i
K+ concentration in the intracellular medium
[Ca2+]i
Ca2+ concentration in the intracellular medium
[Mg2+]i
Mg2+ concentration in the intracellular medium
[Ca2+]d
Ca2+ concentration in the restricted subsarcolemmal space
[Ca2+]up
Ca2+ concentration in the sarcoplasmic reticulum uptake compartment
[Ca2+]rel
Ca2+ concentration in the sarcoplasmic reticulum release compartment
ENa
Equilibrium (Nernst) potential for Na+
EK
Equilibrium (Nernst) potential for K+
ECa
Equilibrium (Nernst) potential for Ca2+
ECa,app
Apparent reversal potential for ICa,L (differs from ECa)
PNa
Permeability for INa
¯gCa,L
Maximum conductance for ICa,L
¯gt
Maximum conductance for It
¯gsus
Maximum conductance for Isus
¯gK,s
Maximum conductance for IK,s
¯gK,r
Maximum conductance for IK,r
¯gK1
Maximum conductance for IK1
¯gB,Na
Maximum conductance for IB,Na
¯gB,Ca
Maximum conductance for IB,Ca
m
Activation gating variable for INa
h1, h2
Fast and slow inactivation gating variables for INa
dL
Activation gating variable for ICa,L
fL1, fL2
Fast and slow inactivation gating variables for ICa,L
fCa
[Ca2+]d-dependent ratio of fast (fL1) to slow (fL2) inactivation of ICa,L
kCa
Half-maximum Ca2+ binding concentration for fCa
r
Activation gating variable for It
s
Inactivation gating variable for It
s1, s2
Rapidly and slowly recovering inactivation gating variables for It
rsus
Activation gating variable for Isus
ssus
Inactivation gating variable for Isus
n
Activation gating variable for IK,s
pa
Activation gating variable for IK,r
pi
Inactivation gating variable (instantaneous) for IK,r
¯m, ¯h1, ...
Steady-state value of m, h1, etc
F1
Relative amount of "inactive precursor" in the Irel formulation
F2
Relative amount of "activator" in the Irel formulation
m
Activation time constant for INa
h1,
h2
Fast and slow inactivation time constants for INa
dL
Activation time constant for ICa,L
fL1,
fL2
Fast and slow inactivation time constants for ICa,L
r
Activation time constant for It
s
Inactivation time constant for It
s1,
s2
Rapidly and slowly recovering inactivation time constants for It
rsus
Activation time constant for Isus
ssus
Inactivation time constant for Isus
n
Activation time constant for IK,s
pa
Activation time constant for IK,r
O
Buffer occupancy
OC
Fractional occupancy of the calmodulin buffer by Ca2+
OTC
Fractional occupancy of the troponin-Ca2+ buffer by Ca2+
OTMgC
Fractional occupancy of the troponin-Mg2+ buffer by Ca2+
OTMgMg
Fractional occupancy of the troponin-Mg2+ buffer by Mg2+
OCalse
Fractional occupancy of the calsequestrin buffer (in the sarcoplasmic reticulum release compartment) by Ca2+
R
Universal gas constant
T
Absolute temperature
F
Faraday's constant
Cm
Membrane capacitance
V
Membrane voltage
Volc
Volume of the extracellular cleft space
Voli
Total cytosolic volume
Vold
Volume of the diffusion-restricted subsarcolemmal space
Volup
Volume of the sarcoplasmic reticulum uptake compartment
Volrel
Volume of the sarcoplasmic reticulum release compartment
Na,
K,
Ca
Time constant of diffusion of Na+, K+, and Ca2+ from the bulk medium to the extracellular cleft space
di
Time constant of diffusion from the restricted subsarcolemmal space to the cytosol
¯INaK
Maximum Na+-K+ pump current
kNaK,K
Half-maximum K+ binding concentration for INaK
kNaK,Na
Half-maximum Na+ binding concentration for INaK
¯ICaP
Maximum Ca2+ pump current
kCaP
Half-maximum Ca2+ binding concentration for ICaP
kNaCa
Scaling factor for INaCa
Position of energy barrier controlling voltage dependence of INaCa
dNaCa
Denominator constant for INaCa
¯Iup
Maximum sarcoplasmic reticulum uptake current
kcyca
Half-maximum binding concentration for [Ca2+]i to Iup
ksrca
Half-maximum binding concentration for [Ca2+]up to Iup
kxcs
Ratio of forward to back reactions for Iup
tr
Time constant of diffusion ("translocation") of Ca2+ from sarcoplasmic reticulum uptake to release compartment
rel
Scaling factor for Irel
krel,i
Half-activation [Ca2+]i for Irel
krel,d
Half-activation [Ca2+]d for Irel
rrecov
Recovery rate constant for the sarcoplasmic reticulum release channel
| Acknowledgments |
|---|
Received June 9, 1997; accepted September 30, 1997.
| References |
|---|
|
|
|---|
2. Firek L, Giles WR. Outward currents underlying repolarization in human atrial myocytes. Cardiovasc Res. 1995;39:3138.
3.
DiFrancesco D, Noble D. A model of cardiac electrical
activity incorporating ionic pumps and concentration changes.
Philos Trans R Soc Lond B Biol Sci. 1985;307:353398.
4. Hilgemann DW, Noble D. Excitation-contraction coupling and extracellular calcium transients in rabbit atrium: reconstruction of basic cellular mechanisms. Proc R Soc Lond B Biol Sci. 1987;230:163205.[Medline] [Order article via Infotrieve]
5. Earm YE, Noble D. A model of the single atrial cell: relation between calcium current and calcium release. Proc R Soc Lond B Biol Sci. 1990;240:8396.[Medline] [Order article via Infotrieve]
6.
Rasmusson RL, Clark JW, Giles WR, Robinson K, Clark
RB, Shibata EF, Campbell DL. A mathematical model of
electrophysiological activity in a bullfrog
atrial cell. Am J Physiol. 1990;259:H370H389.
7.
Rasmusson RL, Clark JW, Giles WR, Shibata EF, Campbell
DL. A mathematical model of a bullfrog cardiac pacemaker cell.
Am J Physiol. 1990;259:H352H369.
8.
Luo C-H, Rudy Y. A model of the
ventricular cardiac action potential: depolarization,
repolarization and their interaction. Circ Res. 1991;68:15011526.
9.
Luo C-H, Rudy Y. A dynamic model of the cardiac
ventricular action potential, I: simulations of ionic
currents and concentration changes. Circ Res. 1994;74:10711096.
10.
Luo C-H, Rudy Y. A dynamic model of the cardiac
ventricular action potential, II: afterdepolarizations,
triggered activity, and potentiation. Circ Res. 1994;74:10971113.
11.
Zeng J, Laurita KR, Rosenbaum DS, Rudy Y. Two
components of the delayed rectifier K+ current in
ventricular myocytes of the guinea pig type: theoretical
formulation and their role in repolarization. Circ Res. 1995;77:140152.
12.
Demir SS, Clark JW, Murphey CR, Giles WR. A
mathematical model of a rabbit sinoatrial node cell. Am J
Physiol. 1994;266:C832C852.
13.
Lindblad DS, Murphey CR, Clark JW, Giles WR. A model of
the action potential and underlying membrane currents in a rabbit
atrial cell. Am J Physiol. 1996;271:H1666H1691.
14. Ilnicki T. Electrophysiological and Mechanical Measurements in Human and Rabbit Atria. Calgary, Canada: University of Calgary; 1987. Thesis.
15.
Sakakibara Y, Wasserstrom JA, Furukawa T, Jia H,
Arentzen CE, Hartz RS, Singer DH. Characterization of the sodium
current in single human atrial myocytes. Circ Res. 1992;71:535546.
16.
Sakakibara Y, Furukawa T, Singer, Donald H, Jia H,
Backer CL, Arentzen CE, Wasserstrom JA. Sodium current in isolated
human ventricular myocytes. Am J Physiol. 1993;265:H1301H1309.
17.
Wendt DJ, Starmer F, Grant AO. Na channel kinetics
remain stable during perforated-patch recordings. Am
J Physiol. 1992;263:C1234C1240.
18. Cohen IS, Strichartz GR. On the voltage-dependent action of tetrodotoxin. Biophys J.. 1977;17:275279.[Medline] [Order article via Infotrieve]
19. Benitah JP, Bailly P, D'Agrosa MC, Da Ponte JP, Delgado C. Slow inward current in single cells isolated from adult human ventricles. Pflugers Arch. 1992;421:176187.[Medline] [Order article via Infotrieve]
20. Escande D, Coulombe A, Faivre J, Coraboeuf E. Characteristics of the time-dependent slow inward current in adult human atrial single myocytes. J Mol Cell Cardiol. 1986;18:547551.[Medline] [Order article via Infotrieve]
21.
Le Grand B, Hatem S, Deroubaix E, Couétil J-P,
Coraboeuf E. Calcium current depression in isolated human atrial
myocytes after cessation of chronic treatment with calcium
antagonists. Circ Res. 1991;69:292300.
22. Le Grand B, Hatem S, Deroubaix E, Couétil J-P, Coraboeuf E. Depressed transient outward and calcium currents in dilated human atria. Cardiovasc Res. 1994;28:548556.[Medline] [Order article via Infotrieve]
23. Mewes T, Ravens U. L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium. J Mol Cell Cardiol. 1994;26:13071320.[Medline] [Order article via Infotrieve]
24. Ouadid H, Seguin J, Richard S, Chaptal PA, Nargeot J. Properties and modulation of Ca channels in adult human atrial cells. J Mol Cell Cardiol. 1991;23:4154.[Medline] [Order article via Infotrieve]
25.
Li GR, Nattel S. Properties of human atrial
ICa at physiological temperatures and
relevance to action potential. Am J Physiol. 1997;272:H227H235.
26. Ouadid H, Albat B, Nargeot J. Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol. 1995;25:282291.[Medline] [Order article via Infotrieve]
27.
Sun XH, Protasi F, Takahashi M, Takeshima H, Ferguson
DG, Franzini-Armstrong C. Molecular architecture of membranes involved
in excitation-contraction coupling of cardiac muscle. J Cell
Biol. 1995;129:659671.
28. Imredy JP, Yue DT. Mechanism of Ca2+-sensitive inactivation of L-type Ca2+ channels. Neuron. 1994;12:13011318.[Medline] [Order article via Infotrieve]
29. You Y, Pelzer DJ, Pelzer S. Trypsin and forskolin decrease the sensitivity of L-type calcium current to inhibition by cytoplasmic free calcium in guinea pig heart muscle cells. Biophys J. 1995;69:18381846.[Medline] [Order article via Infotrieve]
30. Giles WR, Clark RB, Braun AP. Ca2+-independent transient outward current in mammalian heart. In: Morad M, Ebashi S, Trautwein W, Kurachi Y, eds. Molecular Physiology and Pharmacology of Cardiac Ion Channels and Transporters. Amsterdam, the Netherlands: Kluwer Publishing Ltd; 1996:141168.
31.
Escande D, Coulombe A, Faivre JF, Deroubaix E,
Coraboeuf E. Two types of transient outward currents in adult human
atrial cells. Am J Physiol. 1987;252:H142H148.
32. Gross GJ, Burke RP, Castle NA. Characterization of transient outward current in young human atrial myocytes. Cardiovasc Res. 1995;29:112117.[Medline] [Order article via Infotrieve]
33.
Wettwer E, Amos G, Gath J, Zerkowski HR, Reidemeister
JC, Ravens U. Transient outward current in human and rat
ventricular myocytes. Cardiovasc Res. 1993;27:16621669.
34. Fedida D, Wible B, Wang Z, Fermini B, Faust F, Nattel S, Brown AM. Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current. Circ Res. 1993;73:210216.[Abstract]
35.
Wang Z, Fermini B, Nattel S. Sustained
depolarization-induced outward current in human atrial myocytes:
evidence for a novel delayed rectifier K+ current similar
to Kv1.5 cloned channel currents. Circ Res. 1993;73:10611076.
36.
Näbauer M, Beuckelmann DJ, Erdmann E.
Characteristics of transient outward current in human
ventricular myocytes from patients with terminal heart
failure. Circ Res. 1993;73:386394.
37.
Agus ZS, Dukes ID, Morad M. Divalent cations modulate
the transient outward current in rat ventricular myocytes.
Am J Physiol. 1991;261:C310C318.
38.
Fermini B, Wang Z, Duan D, Nattel S. Differences in
rate dependence of transient outward current in rabbit and human
atrium. Am J Physiol. 1992;263:H1747H1754.
39. Koidl B, Flaschberger P, Schaffer P, Pelzmann B, Bernhart E, Mächler H, Rigler B. Effects of the class III antiarrhythmic drug ambasilide on outward currents in human atrial myocytes. Naunyn Schmiedebergs Arch Pharmacol. 1996;353:226232.[Medline] [Order article via Infotrieve]
40.
Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM, Ravens
U. Differences between outward currents of human atrial and
subepicardial ventricular myocytes. J Physiol
(Lond). 1996;491:3150.
41.
Muraki K, Imaizumi Y, Watanabe M, Habuchi Y, Giles WR.
Delayed rectifier K+ current in rabbit atrial myocytes.
Am J Physiol. 1995;269:H524H532.
42.
Wang Z, Fermini B, Nattel S. Delayed rectifier outward
current and repolarization in human atrial myocytes. Circ
Res. 1993;73:276285.
43. Liu S, Rasmusson RL, Campbell DL, Wang S, Strauss HC. Activation and inactivation kinetics of an E-4031-sensitive current from single ferret atrial myocytes. Biophys J. 1996;70:27042715.[Medline] [Order article via Infotrieve]
44. Wang Z, Fermini B, Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res. 1994;28:15401546.[Medline] [Order article via Infotrieve]
45. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81:299307.[Medline] [Order article via Infotrieve]
46. Lide DR, ed. CRC Handbook of Chemistry and Physics. Cleveland, Ohio: CRC Press; 1992.
47.
Kunze DL. Rate-dependent changes in extracellular
potassium in the rabbit atrium. Circ Res. 1977;41:122127.
48.
Cohen I, Kline R. K+ fluctuations in the
extracellular spaces of cardiac muscle: evidence from the voltage-clamp
and extracellular K+-selective microelectrodes. Circ
Res. 1982;50:116.
49.
Parker I, Zang WJ, Wier WG. Ca2+ sparks
involving multiple Ca2+ release sites along Z-lines in rat
heart cells. J Physiol (Lond). 1996;497:3138.
50. Stern MD. Theory of excitation-contraction coupling in cardiac muscle. Biophys J. 1992;63:497517.[Medline] [Order article via Infotrieve]
51.
Isenberg G, Han S. Gradation of
Ca2+-induced Ca2+ release by voltage-clamp
pulse duration in potentiated guinea-pig ventricular
myocytes. J Physiol (Lond). 1994;480:423438.
52.
Bénardeau A, Hatem SN, Rucker-Martin C, Le Grand
B, Mace L, Dervanian P, Mercadier JJ, Coraboeuf E. Contribution of
Na+/Ca2+ exchange to action potential of human
atrial myocytes. Am J Physiol. 1996;271:H1151H1161.
53. Paulsen RA, Clark JW Jr, Murphy PH, Burdine JA. Sensitivity analysis and improved identification of a systemic arterial model. IEEE Trans Biomed Eng. 1982;29:164178.[Medline] [Order article via Infotrieve]
54. Le Grand B, Le Heuzey JY, Perier P, Peronneau P, Lavergne T, Hatem S, Guize L. Cellular electrophysiological effects of flecainide on human atrial fibres. Cardiovasc Res.. 1990;24:232238.[Medline] [Order article via Infotrieve]
55.
Wang Z, Pelletier LC, Talajic M, Nattel S. Effects of
flecainide and quinidine on human atrial action potentials: role of
rate-dependence and comparison with guinea pig, rabbit, and dog
tissues. Circulation. 1990;82:274283.
56.
Wang Z, Fermini B, Nattel S. Effects of flecainide,
quinidine, and 4-aminopyridine on transient outward and
ultrarapid delayed rectifier currents in human atrial myocytes.
J Pharmacol Exp Ther. 1995;272:184196.
57. Kottkamp H, Haverkamp W, Borggrefe M, Breithardt G. The role of class III antiarrhythmic drugs in atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation: Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co Inc; 1994:287306.
58.
Li G-R, Feng J, Wang Z, Fermini B, Nattel S. Adrenergic
modulation of ultrarapid delayed rectifier K+ current in
human atrial myocytes. Circ Res. 1995;78:903915.
59.
Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS,
Nerbonne JM. Outward K+ current densities and Kv1.5
expression are reduced in chronic human atrial fibrillation. Circ
Res. 1997;80:772781.
60.
Yue L, Feng J, Li GR, Nattel S. Transient outward and
delayed rectifier currents in canine atrium: properties and role of
isolation methods. Am J Physiol. 1996;270:H2157H2168.
61. Clark RB, Sanchez-Chapula J, Salinas-Stefanon E, Duff HJ, Giles WR. Quinidine-induced open channel block of K+ current in rat ventricle. Br J Pharmacol. 1995;115:335343.[Medline] [Order article via Infotrieve]
62.
Hatem SN, Bénardeau A, Rücker-Martin C,
Marty I, de Chamisso P, Villaz M, Mercadier J-J. Different compartments
of sarcoplasmic reticulum participate in the excitation-contraction
coupling process in human atrial myocytes. Circ Res. 1997;80:345353.
This article has been cited by other articles:
![]() |
M. M. Maleckar, J. L. Greenstein, W. R. Giles, and N. A. Trayanova K+ current changes account for the rate dependence of the action potential in the human atrial myocyte Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1398 - H1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Fenton, S. Luther, E. M. Cherry, N. F. Otani, V. Krinsky, A. Pumir, E. Bodenschatz, and R. F. Gilmour Jr Termination of Atrial Fibrillation Using Pulsed Low-Energy Far-Field Stimulation Circulation, August 11, 2009; 120(6): 467 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Severi, C. Corsi, and E. Cerbai From in vivo plasma composition to in vitro cardiac electrophysiology and in silico virtual heart: the extracellular calcium enigma Phil Trans R Soc A, June 13, 2009; 367(1896): 2203 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stewart, O. V. Aslanidi, D. Noble, P. J. Noble, M. R. Boyett, and H. Zhang Mathematical models of the electrical action potential of Purkinje fibre cells Phil Trans R Soc A, June 13, 2009; 367(1896): 2225 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Linge, J. Sundnes, M. Hanslien, G.T. Lines, and A. Tveito Numerical solution of the bidomain equations Phil Trans R Soc A, May 28, 2009; 367(1895): 1931 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nattel Delayed-rectifier potassium currents and the control of cardiac repolarization: Noble and Tsien 40 years after J. Physiol., December 15, 2008; 586(24): 5849 - 5852. [Full Text] [PDF] |
||||
![]() |
A. Garny, D. P Nickerson, J. Cooper, R. W. d. Santos, A. K Miller, S. McKeever, P. M.F Nielsen, and P. J Hunter CellML and associated tools and techniques Phil Trans R Soc A, September 13, 2008; 366(1878): 3017 - 3043. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Mangoni and J. Nargeot Genesis and Regulation of the Heart Automaticity Physiol Rev, July 1, 2008; 88(3): 919 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Landeen, D. A. Dederko, C. S. Kondo, B. S. Hu, N. Aroonsakool, J. H. Haga, and W. R. Giles Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H736 - H749. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Olypher and R. L. Calabrese Using Constraints on Neuronal Activity to Reveal Compensatory Changes in Neuronal Parameters J Neurophysiol, December 1, 2007; 98(6): 3749 - 3758. [Abstract] [Full Text] [PDF] |
||||
![]() |
Choon Kiat Sim and D. B. Forger Modeling the Electrophysiology of Suprachiasmatic Nucleus Neurons J Biol Rhythms, October 1, 2007; 22(5): 445 - 453. [Abstract] [PDF] |
||||
![]() |
B. London, C. Albert, M. E. Anderson, W. R. Giles, D. R. Van Wagoner, E. Balk, G. E. Billman, M. Chung, W. Lands, A. Leaf, et al. Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research: A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop Circulation, September 4, 2007; 116(10): e320 - e335. [Full Text] [PDF] |
||||
![]() |
K. Tsujimae, S. Suzuki, S. Murakami, and Y. Kurachi Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H660 - H669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. B. Jacobsen, C. Aalkjaer, H. Nilsson, V. V. Matchkov, J. Freiberg, and N.-H. Holstein-Rathlou Activation of a cGMP-sensitive calcium-dependent chloride channel may cause transition from calcium waves to whole cell oscillations in smooth muscle cells Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H215 - H228. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Qu, V. E. Bondarenko, C. Xie, S. Wang, M. S. Awayda, H. C. Strauss, and M. J. Morales W-7 modulates Kv4.3: pore block and Ca2+-calmodulin inhibition Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2364 - H2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Noble From the Hodgkin-Huxley axon to the virtual heart J. Physiol., April 1, 2007; 580(1): 15 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Otway, J. I. Vandenberg, G. Guo, A. Varghese, M. L. Castro, J. Liu, J. Zhao, J. A. Bursill, K. R. Wyse, H. Crotty, et al. Stretch-Sensitive KCNQ1 Mutation: A Link Between Genetic and Environmental Factors in the Pathogenesis of Atrial Fibrillation? J. Am. Coll. Cardiol., February 6, 2007; 49(5): 578 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Cherry and F. H. Fenton A tale of two dogs: analyzing two models of canine ventricular electrophysiology Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H43 - H55. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fink, W. R Giles, and D. Noble Contributions of inwardly rectifying K+ currents to repolarization assessed using mathematical models of human ventricular myocytes Phil Trans R Soc A, May 15, 2006; 364(1842): 1207 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Pollard and R. C. Barr Cardiac microimpedance measurement in two-dimensional models using multisite interstitial stimulation Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1976 - H1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ochi, Y. Momose, K. Oyama, and W. R. Giles Sphingosine-1-phosphate effects on guinea pig atrial myocytes: Alterations in action potentials and K+ currents Cardiovasc Res, April 1, 2006; 70(1): 88 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qu Critical mass hypothesis revisited: role of dynamical wave stability in spontaneous termination of cardiac fibrillation Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H255 - H263. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qu and J. N. Weiss Effects of Na+ and K+ channel blockade on vulnerability to and termination of fibrillation in simulated normal cardiac tissue Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1692 - H1701. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Krogh-Madsen, P. Schaffer, A. D. Skriver, L. K. Taylor, B. Pelzmann, B. Koidl, and M. R. Guevara An ionic model for rhythmic activity in small clusters of embryonic chick ventricular cells Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H398 - H413. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, C. J. Garratt, J. Zhu, and A. V. Holden Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans Cardiovasc Res, June 1, 2005; 66(3): 493 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Terrenoire, C. E. Clancy, J. W. Cormier, K. J. Sampson, and R. S. Kass Autonomic Control of Cardiac Action Potentials: Role of Potassium Channel Kinetics in Response to Sympathetic Stimulation Circ. Res., March 18, 2005; 96(5): e25 - e34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Goodman, R. A. Oliver, C. S. Henriquez, and P. D. Wolf A membrane model of electrically remodelled atrial myocardium derived from in vivo measurements Europace, January 1, 2005; 7(s2): S135 - S145. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Winslow and J. L. Greenstein The Ongoing Journey to Understand Heart Function Through Integrative Modeling Circ. Res., December 10, 2004; 95(12): 1135 - 1136. [Full Text] [PDF] |
||||
![]() |
K. Zorn-Pauly, P. Schaffer, B. Pelzmann, P. Lang, H. Machler, B. Rigler, and B. Koidl If in left human atrium: a potential contributor to atrial ectopy Cardiovasc Res, November 1, 2004; 64(2): 250 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wettwer, O. Hala, T. Christ, J. F. Heubach, D. Dobrev, M. Knaut, A. Varro, and U. Ravens Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation Circulation, October 19, 2004; 110(16): 2299 - 2306. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Trepanier-Boulay, M.-A. Lupien, C. St-Michel, and C. Fiset Postnatal development of atrial repolarization in the mouse Cardiovasc Res, October 1, 2004; 64(1): 84 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Bondarenko, G. P. Szigeti, G. C. L. Bett, S.-J. Kim, and R. L. Rasmusson Computer model of action potential of mouse ventricular myocytes Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1378 - H1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Noble Modeling the Heart Physiology, August 1, 2004; 19(4): 191 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, H. Wang, Y. Zhang, H. Gao, S. Nattel, and Z. Wang Impairment of HERG K+ Channel Function by Tumor Necrosis Factor-{alpha}: ROLE OF REACTIVE OXYGEN SPECIES AS A MEDIATOR J. Biol. Chem., April 2, 2004; 279(14): 13289 - 13292. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. KLEBER and Y. RUDY Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias Physiol Rev, April 1, 2004; 84(2): 431 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Lomax, C. S. Kondo, and W. R. Giles Comparison of time- and voltage-dependent K+ currents in myocytes from left and right atria of adult mice Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1837 - H1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Fridlyand, N. Tamarina, and L. H. Philipson Modeling of Ca2+ flux in pancreatic {beta}-cells: role of the plasma membrane and intracellular stores Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E138 - E154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brouillette, V. Trepanier-Boulay, and C. Fiset Effect of androgen deficiency on mouse ventricular repolarization J. Physiol., January 15, 2003; 546(2): 403 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kurata, I. Hisatome, S. Imanishi, and T. Shibamoto Dynamical description of sinoatrial node pacemaking: improved mathematical model for primary pacemaker cell Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2074 - H2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Xie, Z. Qu, A. Garfinkel, and J. N. Weiss Electrical refractory period restitution and spiral wave reentry in simulated cardiac tissue Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H448 - H460. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Bernus, R. Wilders, C. W. Zemlin, H. Verschelde, and A. V. Panfilov A computationally efficient electrophysiological model of human ventricular cells Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2296 - H2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kneller, R. Zou, E. J. Vigmond, Z. Wang, L. J. Leon, and S. Nattel Cholinergic Atrial Fibrillation in a Computer Model of a Two-Dimensional Sheet of Canine Atrial Cells With Realistic Ionic Properties Circ. Res., May 17, 2002; 90 (9): e73 - e87. [Abstract] [Full Text] [PDF] |
||||
![]() |
Members of the Sicilian Gambit New Approaches to Antiarrhythmic Therapy, Part I: Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias Circulation, December 4, 2001; 104(23): 2865 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
Members of the Sicilian Gambit New approaches to antiarrhythmic therapy; emerging therapeutic applications of the cell biology of cardiac arrhythmias Eur. Heart J., December 1, 2001; 22(23): 2148 - 2163. [Abstract] [PDF] |
||||
![]() |
J. L. Puglisi and D. M. Bers LabHEART: an interactive computer model of rabbit ventricular myocyte ion channels and Ca transport Am J Physiol Cell Physiol, December 1, 2001; 281(6): C2049 - C2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
Members of the Sicilian Gambit New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias Cardiovasc Res, December 1, 2001; 52(3): 345 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Restivo, D. O. Kozhevnikov, and M. Boutjdir Optical mapping of activation patterns in an animal model of congenital heart block Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1889 - H1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Ramirez, S. Nattel, and M. Courtemanche Mathematical analysis of canine atrial action potentials: rate, regional factors, and electrical remodeling Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1767 - H1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
David M. Harrild, Craig S. Henriquez ; A Computer Model of Normal Conduction in the Human Atria Circ. Res., September 29, 2000; 87 (7): e25 - e36. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Spach, J. F. Heidlage, P. C. Dolber, and R. C. Barr Electrophysiological Effects of Remodeling Cardiac Gap Junctions and Cell Size : Experimental and Model Studies of Normal Cardiac Growth Circ. Res., February 18, 2000; 86(3): 302 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Courtemanche, R. J Ramirez, and S. Nattel Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model Cardiovasc Res, May 1, 1999; 42(2): 477 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Priebe and D. J. Beuckelmann Simulation Study of Cellular Electric Properties in Heart Failure Circ. Res., June 15, 1998; 82(11): 1206 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kneller, R. J. Ramirez, D. Chartier, M. Courtemanche, and S. Nattel Time-dependent transients in an ionically based mathematical model of the canine atrial action potential Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1437 - H1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Bernus, R. Wilders, C. W. Zemlin, H. Verschelde, and A. V. Panfilov A computationally efficient electrophysiological model of human ventricular cells Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2296 - H2308. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |